TCL Archive Study Would Try to Validate EGFR FISH as Predictive Marker for Benefit from Tarceva. July 13, 2007
TCL Archive The Line Item for Cancer Centers and SPOREs to Remain Flat, Near $598 Million for the 2013 Fiscal Year April 20, 2012